Safety of cryoballoon ablation for the treatment of atrial fibrillation: First European results from the cryo AF Global Registry
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F21%3A00009072" target="_blank" >RIV/00023884:_____/21:00009072 - isvavai.cz</a>
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/10.1111/pace.14237" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1111/pace.14237</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/pace.14237" target="_blank" >10.1111/pace.14237</a>
Alternative languages
Result language
angličtina
Original language name
Safety of cryoballoon ablation for the treatment of atrial fibrillation: First European results from the cryo AF Global Registry
Original language description
Background Cryoballoon ablation for the treatment of patients with atrial fibrillation (AF) has been utilized in Europe for >15 years. Objectives Report patient and procedural characteristics that influence the safety of cryoablation for the treatment of AF. Methods Patients enrolled in the prospective, multicenter Cryo AF Global Registry were treated at 38 European centers. Freedom from a >= 30s episode of AF/atrial flutter (AFL)/atrial tachycardia (AT) at 12-months and serious complications were analyzed. Univariate and multivariable models identified baseline patient and procedural characteristics that predicted a procedure-related complication. Results Of the 1418 subjects who completed an index procedure, the cohort was 62 +/- 11 years of age, 37.7% female, and 72.2% paroxysmal AF (PAF). The mean procedure, left atrial dwell, and fluoroscopy times were 81 +/- 34, 54 +/- 25, and 14 +/- 13 min, respectively. Among the 766 patients with 12-month follow-up, freedom from a >= 30 s AF/AFL/AT recurrence was 83.3% (95% CI: 79.8%-86.3%) and 71.6% (95% CI: 64.6%-77.4%) in patients with PAF and persistent AF. The serious procedure- and device-related adverse event rates were 4.7% and 2.0%. No baseline patient characteristic independently predicted a procedure-related adverse event; however, prolonged procedure duration (OR = 1.01 [95% CI: 1.00-1.01]), use of general anesthesia (OR = 1.71 [95% CI: 1.01-2.92]), and delivery of a cavotricuspid isthmus line (OR = 3.04 [95% CI: 1.01-9.20]) were each independently associated with the occurrence of a serious procedural safety event (all p < .05).
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
PACE: Pacing and clinical electrophysiology
ISSN
0147-8389
e-ISSN
—
Volume of the periodical
44
Issue of the periodical within the volume
5
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
883-894
UT code for WoS article
000646716400001
EID of the result in the Scopus database
2-s2.0-85104521363